ライフサイエンスコーパス: nonmedical

1 inancial outcomes, below-prime credit score, nonmedical and medical debt in collections, delinquent d

2 lence of exemptions to vaccine requirements (nonmedical and medical).

3 od vaccination, driven by vaccine hesitancy (nonmedical and personal belief exemptions), will have su

4 MS), we estimated the direct medical, direct nonmedical, and indirect (productivity losses) costs bor

5 We collected direct medical, nonmedical, and indirect costs per blood culture-confirm

6 er perspective, we collected direct medical, nonmedical, and indirect costs per case of enteric fever

7 later to estimate the direct medical, direct nonmedical, and indirect costs.

8 Mean annual medical, nonmedical, and indirect economic costs and lifetime cos

9 mic and nonophthalmic direct medical, direct nonmedical, and indirect medical (productivity) costs sa

10 ary outcomes included the amount of medical, nonmedical, and total debt among individuals with nonzer

11 ily adaptable to both human clinical use and nonmedical applications for a variety of solids in mater

12 here are several other potential medical and nonmedical applications for synthetic transmembrane anio

13 mplants and diagnostics, as well as numerous nonmedical applications in which the minimization of sur

14 he ethical and social issues associated with nonmedical applications of genetic variation research.

15 antibacterial activity and drug delivery, to nonmedical applications such as biomimicry, the developm

16 and is moreover used in various medical and nonmedical applications.

17 Within several nonmedical areas (eg, aviation, nuclear power), concepts

18 to medical research and information, various nonmedical barriers and lack of reports describing appro

19 ant secondary trial end point and to measure nonmedical burdens, including time and financial toxicit

20 r time, which may have accelerated following nonmedical cannabis commercialization.

21 cal cannabis in 2015 and the legalization of nonmedical cannabis in 2018.

22 The impact of nonmedical cannabis legalization on traffic injuries and

23 orted psychotic disorders with indicators of nonmedical cannabis use (any use; frequent use [at least

24 mine prevalence and frequency of medical and nonmedical cannabis use among pregnant and nonpregnant w

25 rs examined differences in the prevalence of nonmedical cannabis use and cannabis use disorder among

26 c regression analyses tested associations of nonmedical cannabis use and cannabis use disorder with d

27 elf-reported psychotic disorder and frequent nonmedical cannabis use and cannabis use disorder.

28 th pain may be an emerging group at risk for nonmedical cannabis use and cannabis use disorder.

29 rder, and psychiatric disorder correlates of nonmedical cannabis use and cannabis use disorder; and t

30 Medical and nonmedical cannabis use and cannabis use disorders (CUD)

31 Sociodemographic correlates of nonmedical cannabis use and use disorder included younge

32 Nonmedical cannabis use and use disorder were associated

33 Among veterans, the odds of nonmedical cannabis use and use disorder were elevated a

34 eening in Washington state where medical and nonmedical cannabis use are legal.

35 The prevalence of frequent nonmedical cannabis use did not differ by pain status in

36 y more prevalent among participants with any nonmedical cannabis use than those without.

37 Any nonmedical cannabis use was more prevalent in respondent

38 Risk differences of past-year nonmedical cannabis use, frequent (at least three times

39 frequent use and those with daily/near-daily nonmedical cannabis use.

40 order) compared with those with no past-year nonmedical cannabis use.

41 abis use disorder prevalence estimates among nonmedical cannabis users were 24.4% and 17.4%, respecti

42 elegalization, liberalization of medical and nonmedical cannabis, and legalization of nonmedical cann

43 and nonmedical cannabis, and legalization of nonmedical cannabis.

44 enting firearm suicide among females through nonmedical care settings.

45 en, provided the majority of assistance with nonmedical care.

46 Patients with a nonmedical cause of OHCAs were excluded.

47 out psychiatric illness and to identify the nonmedical causes for pain and disability.

48 re male sex, older age, receipt of care in a nonmedical center, higher Charlson Comorbidity Index sco

49 ion of the California policy that eliminated nonmedical childhood vaccine exemptions was associated w

50 (n = 168, 26.1%), a friend (n = 112, 17.4%), nonmedical clinic staff (n = 100, 15.5%), a clinic docto

51 ficials began recommending widespread use of nonmedical cloth masks to reduce the transmission of SAR

52 6.5%-37.3%] vs 23.9% [95% CI, 23.7%-24.2%]), nonmedical collections (38.4% [95% CI, 38.0%-38.8%] vs 2

53 been a strong emphasis from both medical and nonmedical communities to improve overall cardiovascular

54 ermined vulnerabilities (SDV), which include nonmedical conditions that contribute to patient health,

55 ective includes direct medical costs; direct nonmedical costs (caregiver, transportation, residence);

56 d to offset the burden of direct medical and nonmedical costs are required to improve the financial h

57 report direct medical, indirect medical, and nonmedical costs of diabetic retinopathy in developed an

58 ed the direct medical, indirect medical, and nonmedical costs of DR in developed and developing count

59 Median direct medical and nonmedical costs per case represented ~3.5% of annual in

60 Median direct medical and nonmedical costs per case were 3% of annual labor income

61 The median direct medical and nonmedical costs represented 8.2% of the annual labor in

62 g facility, nursing home and others), direct nonmedical costs saved (decreased costs for caregivers,

63 Considering indirect nonmedical costs SLIT resulted more cost-effective than

64 The CE ratios decreased 50% if direct nonmedical costs were included and increased 50% if DTIC

65 rhea, including direct medical costs, direct nonmedical costs, and productivity losses.

66 a range of TEM's efficacy and costs, direct nonmedical costs, and the DTIC schedule.

67 rvention costs, direct medical costs, direct nonmedical costs, productivity losses, and health-relate

68 currently available products, plus indirect nonmedical costs, such as travel and productivity costs)

69 ikely to result in higher direct medical and nonmedical costs.

70 ts to infer health conditions and risks from nonmedical data provides representative scenarios for re

71 y pretraining a "generic network" on a large nonmedical data set and then fine-tuning on a task-speci

72 asks, compared with transfer learning from a nonmedical data set, SupCon reduced label requirements u

73 h vs without diabetes, the maximum amount of nonmedical debt in collection was higher ($1875 vs $1361

74 dical debt in collections (7.6% vs 32%), any nonmedical debt in collections (7.2% vs 24%), any delinq

75 6% had medical debt in collections, 8.3% had nonmedical debt in collections, 16.3% had delinquent deb

76 ility of having medical debt in collections, nonmedical debt in collections, any delinquent debt, a l

77 their prognosis informs numerous medical and nonmedical decisions, but patients with cancer and their

78 Data on medical and nonmedical direct costs and indirect costs were establis

79 medical direct costs, 685,000 US dollars in nonmedical direct costs, and 1.5 million US dollars in i

80 entions to prevent initiation of illicit and nonmedical drug use among adolescents and young adults w

81 es that easily granted exemptions had higher nonmedical exemption rates in 2002 through 2003 compared

82 mitted personal belief exemptions had higher nonmedical exemption rates than states that offered only

83 asles, mumps, and rubella (MMR) vaccination, nonmedical exemption, and medical exemption in children

84 accine eligible and 405 (70.6%) of these had nonmedical exemptions (eg, exemptions for religious or p

85 r consideration before policies to eliminate nonmedical exemptions are implemented widely and outline

86 lyzed 1991 through 2004 state-level rates of nonmedical exemptions at school entry and 1986 through 2

87 e in vaccination coverage and a reduction in nonmedical exemptions at state and county levels.

88 The clustering of nonmedical exemptions can affect community risk of vacci

89 gs suggest that government policies removing nonmedical exemptions can be effective at increasing vac

90 tes evaluated in the placebo tests, top 5%), nonmedical exemptions decreased by 2.4% (top 2 of 43 sta

91 fidence interval [CI] 2.9%-5.8%, p < 0.001), nonmedical exemptions decreased by 3.9% (95% CI 2.4%-5.4

92 udy suggest that legislative action to limit nonmedical exemptions for compulsory vaccination for sch

93 lifornia policy (Senate Bill 277) eliminated nonmedical exemptions from school entry requirements.

94 The authors evaluated spatial clustering of nonmedical exemptions in Michigan and geographic overlap

95 underlying the policy decision to eliminate nonmedical exemptions is clearly articulated.

96 Passage of SB 277, which eliminated nonmedical exemptions to childhood immunizations for sch

97 rst state in more than 30 years to eliminate nonmedical exemptions to mandatory childhood immunizatio

98 Forty-eight states offer nonmedical exemptions to school immunization requirement

99 Most states offer nonmedical exemptions to school requirements (religious

100 vaccine hesitancy as well as the removal of nonmedical exemptions were estimated.

101 basis of religious or personal beliefs (ie, nonmedical exemptions) may be a useful strategy to incre

102 ptions was offset by the larger reduction in nonmedical exemptions.

103 Data on OOP direct medical and nonmedical expenditures and household consumption expend

104 er wearing a 3-layer plane-shaped disposable nonmedical face mask widely used to protect against COVI

105 Nonmedical factors are important determinants of whether

106 Therefore, studying nonmedical factors is critical to understanding disparit

107 To control for the influence of nonmedical factors on survival, we assumed in our base-c

108 The influence of nonmedical factors on the disposition of TBI patients in

109 ve services, but disparities on the basis of nonmedical factors still exist.

110 We found that nonmedical factors strongly influenced prioritization ac

111 uable as a first step in identifying the key nonmedical factors that play a role in this disparity.

112 concerns practice variability attributed to nonmedical factors, and growing attention to outcomes re

113 apy receipt can be influenced by medical and nonmedical factors.

114 ployment, which is primarily associated with nonmedical factors.

115 s were conducted among 40 professionals from nonmedical fields to investigate antiracism practices us

116 Among 40 professionals from nonmedical fields, most were younger than age 40 years (

117 rtment type, minority status, medical versus nonmedical final degree, and school.

118 l and economic impact of a program providing nonmedical financial assistance on missed treatment appo

119 novel approach to retrospectively evaluate a nonmedical financial assistance program for patients und

120 pointment averted, relative to not providing nonmedical financial assistance.

121 nvestment in programs that address patients' nonmedical financial needs, particularly for those under

122 multicomponent stepped-care program led by a nonmedical health care worker.

123 nd carriage of S. aureus between medical and nonmedical hospital personnel were examined.

124 although the principles apply to medical and nonmedical images; authors also explore mathematical and

125 6%) had scheduled CDs performed for either a nonmedical indication or a repeated indication, although

126 Nonmedical indications for CD are those not associated w

127 Moreover, directed donation for nonmedical indications lacks scientific justification.

128 No surveys asked participants about nonmedical injection of prescription drugs.

129 chiatrically ill persons may be addressed by nonmedical interventions of reassurance and support.

130 measurements that consider literacy and use nonmedical language.

131 C), a means-tested reimbursement program for nonmedical LD costs.

132 ls examined whether time trends in past-year nonmedical LSD use differed between adults with vs witho

133 Subsequent review excluded 350 apps due to nonmedical nature, non-English languages, absence of AI

134 ecurity, 121 (66.9%) accepted a referral for nonmedical needs assistance.

135 very good idea for health systems to address nonmedical needs at the time of surgery, and 27 patients

136 ip for Americans and a threat to medical and nonmedical needs.

137 likely to be nonophthalmologists or to hold nonmedical, non-PhD degrees.

138 ferent professional scenarios and included 2 nonmedical observers.

139 was also associated with increased incident nonmedical opioid use (adjusted odds ratio=2.99, 95% CI=

140 use was also associated with an increase in nonmedical opioid use (adjusted odds ratio=3.13, 95% CI=

141 One of the main aims of research on nonmedical opioid use (NMOU) is to reduce the frequency

142 receiving opioid therapy for pain engage in nonmedical opioid use (NMOU) or diversion, untoward cons

143 Among adults with nonmedical opioid use at wave 1, cannabis use was also a

144 s with moderate or more severe pain and with nonmedical opioid use at wave 1.

145 pairment, resulting in high relapse rates to nonmedical opioid use even years after drug cessation (p

146 blems, and, in opioid use disorder analyses, nonmedical opioid use.

147 r adjustment for background characteristics (nonmedical opioid use: adjusted odds ratio=2.62, 95% CI=

148 Evidence suggests that nonmedical opioid users quite commonly use other drugs,

149 pioid abstinence, and prevention of retaking nonmedical opioids.

150 Several areas of nonmedical options for the management of osteoporosis in

151 Of these 273 deaths, 187 (68%) were due to nonmedical or traumatic causes, 80 (29%) to medical caus

152 e exposure on DED symptoms among medical and nonmedical Palestinian university students.

153 national level, including legislation around nonmedical (personal-belief) exemptions for childhood va

154 State policies that eliminate nonmedical ("personal belief") exemptions to childhood v

155 with more antibiotic-resistant isolates than nonmedical personnel (mean, 2.8 versus 2.1 isolates [P <

156 rates of hand carriage of S. aureus (18% of nonmedical personnel and 10% of medical personnel).

157 on the outcomes when the devices are used by nonmedical personnel for out-of-hospital cardiac arrest.

158 Rapid defibrillation by nonmedical personnel using an automated external defibri

159 entions to prevent or reduce illicit drug or nonmedical pharmaceutical use in children and adolescent

160 ee trials also reported positive outcomes in nonmedical prescription drug use occasions.

161 automatically characterizing a large Twitter nonmedical prescription medication use (NPMU) cohort (n

162 ave 1 was associated with increased incident nonmedical prescription opioid use (odds ratio=5.78, 95%

163 ciated with a change in the risk of incident nonmedical prescription opioid use and opioid use disord

164 rather than decrease the risk of developing nonmedical prescription opioid use and opioid use disord

165 tween cannabis use at wave 1 (2001-2002) and nonmedical prescription opioid use and prescription opio

166 Nonmedical prescription opioid use and use disorders.

167 ); cannabis use disorder (CUD, n = 954); and nonmedical prescription opioid use disorder (NMPOUD, n =

168 revalence of tobacco, alcohol, cannabis, and nonmedical prescription stimulant use among Canadian med

169 physicians (n = 10), patients (n = 27), and nonmedical professionals whose occupations involve inten

170 rposes, BCIs may also hold great promise for nonmedical purposes to unlock human neurocognitive poten

171 sified with certainty as diverting drugs for nonmedical purposes.

172 in Denmark who had undergone an abortion for nonmedical reasons between 1999 and 2004 and obtained in

173 opt out of the donor evaluation process for nonmedical reasons is important for assessing donor volu

174 are patients who use cannabis for medical or nonmedical reasons is unknown for patients in states wit

175 infliximab to biosimilar infliximab-abda for nonmedical reasons were reviewed.

176 dropped out of the acute phase treatment for nonmedical reasons.

177 ess racial disparities in KT incorporate key nonmedical risk factors in patients.

178 s risk in perspective with other medical and nonmedical risks.

179 re identified in 279 decedents (94.6%), with nonmedical routes of exposure and illicit contributory d

180 diction is commonly identified with habitual nonmedical self-administration of drugs.

181 spital-onset sepsis and hospitalization on a nonmedical service were significant predictors of failur

182 Admissions to nonmedical services and admissions for overnight observa

183 y health-related benefits (PHRBs) to include nonmedical services in 2019.

184 pportunities Pilots (HOP) program allows for nonmedical services to address health-related social nee

185 ospital discharge, with similar survival for nonmedical settings (45% [14/31]) and out-of-hospital me

186 e methods for measuring serum cholesterol in nonmedical settings may eventually contribute to the saf

187 While recreational use in nonmedical settings may still cause harm, especially due

188 , also known as "ecstasy," is widely used in nonmedical settings.

189 e of SARS-CoV-2 Ag tests in both medical and nonmedical settings.

190 ires medical knowledge, clinical skills, and nonmedical skills, or crisis resource management (CRM) s

191 n, the drug is most frequently obtained from nonmedical sources as part of a broader and longer-term

192 ormation from the internet, books, and other nonmedical sources.

193 Nonmedical specific services for immigrants can be effec

194 undus images for PDR) interpreted by trained nonmedical staff (ophthalmic graders) to detect reactiva

195 e examples, samples were collected mainly by nonmedical staff and analyses were conducted in the surv

196 tic teams, in particular because the role of nonmedical staff as assistants and anaesthesia providers

197 being extended both by the increased use of nonmedical staff to administer anaesthesia and by the us

198 pporting seizure risk in unstable alcohol or nonmedical stimulant use.

199 l study that was conducted among medical and nonmedical students in the largest five major universiti

200 259 (60.8) were medical and 167 (39.2) were nonmedical students.

201 In this cohort study from Denmark, a nonmedical switch from adalimumab originator to adalimum

202 elated to patients, communication, academic, nonmedical tasks, and transition.

203 Nonmedical therapies are playing an increasing role in t

204 ients and caregivers preferred to start with nonmedical treatments and to step up therapy with increa

205 no evidence supporting the efficacy of other nonmedical treatments such as laser photocoagulation.

206 Hospital-onset sepsis and nonmedical units may be high-yield targets for quality i

207 sess the prevalence of DED among medical and nonmedical university students.

208 ns are associated with higher and increasing nonmedical US exemption rates.

209 Assessing the medical and nonmedical use (NMU) of stimulants and diversion is a ch

210 n was associated with lifetime and past-year nonmedical use (odds ratios, 1.6 and 1.9, respectively)

211 however, unused opioids may be diverted for nonmedical use and contribute to opioid-related injuries

212 n West Virginia in 2006 were associated with nonmedical use and diversion of pharmaceuticals, primari

213 Prevalence of nonmedical use and use disorders and related risk factor

214 Reported nonmedical use did not change significantly among colleg

215 can obtain multiple opioid prescriptions for nonmedical use from different unknowing physicians.

216 The authors compared risk of nonmedical use in individuals in a national sample with

217 The nonmedical use of 'designer' cathinone analogs, such as

218 ven the current crisis, it is vital that the nonmedical use of antibiotics is critically examined and

219 Nonmedical use of prescription and nonprescription drugs

220 trol center records demonstrate an increased nonmedical use of prescription and over-the-counter coug

221 The risk of nonmedical use of prescription anxiety medication and as

222 vorced, or widowed, while being employed and nonmedical use of prescription drugs were associated wit

223 tions to prevent illicit drug use, including nonmedical use of prescription drugs, in children, adole

224 The nonmedical use of prescription medications may result in

225 proportion of those reporting initiation of nonmedical use of prescription opioids before initiating

226 aged 18 through 64 years, the prevalence of nonmedical use of prescription opioids decreased from 5.

227 aged 18 through 64 years, the percentage of nonmedical use of prescription opioids decreased.

228 The mean number of days of nonmedical use of prescription opioids increased from 2.

229 The nonmedical use of prescription opioids preceding heroin

230 Prevalence of nonmedical use of prescription opioids.

231 s in morbidity and mortality associated with nonmedical use of prescription opioids.

232 on-deficit/hyperactivity disorder (ADHD) and nonmedical use of prescription stimulants (NUPS) at the

233 Nonmedical use of psychostimulants for cognitive enhance

234 The nonmedical use of synthetic cathinones is increasing on

235 n for anxiety medications is associated with nonmedical use of these medications, although the direct

236 iduals with anxiety disorders are at risk of nonmedical use of these medications, but information abo

237 portant reservoir of opioids contributing to nonmedical use of these products, which could cause inju

238 edical use only, 25.1% (95% CI, 17.8%-34.2%) nonmedical use only, and 32.5% (95% CI, 25.3%-40.8%) bot

239 s use in the past 30 days: medical use only, nonmedical use only, and both reasons.

240 dents who received a prescription (N=4,294), nonmedical use was associated with male sex, younger age

241 rescription, characteristics associated with nonmedical use were analyzed.

242 7 (17.9%) reported systematic measurement of nonmedical use, and 15 (38.5%) assessed development of t

243 r medical use, 7.2% (95% CI, 3.9%-10.4%) for nonmedical use, and 7.5% (95% CI, 5.7%-9.4%) for both re

244 use, frequent (at least three times a week) nonmedical use, and DSM-IV cannabis use disorder were es

245 d identified characteristics associated with nonmedical use.

246 re prevalent among patients who reported any nonmedical use.

247 Illicit and nonmedical (use in ways other than instructed) drug use

248 ving prescription opioid use disorders among nonmedical users increased to 15.7% (95% CI, 13.87%-17.6

249 can be tailored for a variety of medical or nonmedical uses and sustainably sourced and recycled in

250 YS) recently adopted legislation eliminating nonmedical vaccination exemption options from school-ent

251 study suggested that repeal of school-entry nonmedical vaccination exemptions was associated with in

252 assed in June 2019, eliminating school-entry nonmedical vaccination exemptions.

253 sles outbreak in 2019 amidst rising rates of nonmedical vaccine exemptions (NMEs) and low vaccination

254 this study sought to understand the role of nonmedical vaccine exemptions and waning immunity may ha

255 nt with the view that geographic clusters of nonmedical vaccine exemptions and waning immunity may ha

256 Eight statistically significant clusters of nonmedical vaccine exemptions in kindergarteners and 11

257 statistics, SaTScan, version 9.4, to analyze nonmedical vaccine exemptions of children entering kinde

258 The proportion of kindergarteners with nonmedical vaccine exemptions was 2.8 times larger in th

259 the counties in the study had high rates of nonmedical vaccine exemptions.